HL Science Co Ltd
HL Science Co Ltd is a food processing company that operates in the consumer non-cyclicals sector, primarily generating revenue through the production and sale of food products.
Business. HL Science Co Ltd (239610.KQ) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in South Korea and is primarily listed on the KOSDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
HL Science Co Ltd (239610.KQ) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in South Korea and is primarily listed on the KOSDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
HL Science Co Ltd exhibits a capital structure with a negligible debt-to-equity ratio of 0.0, indicating a strong equity position relative to its liabilities. The company's liquidity is assessed as medium, with a current ratio of 12.23, suggesting it has sufficient current assets to cover its current liabilities. However, the company's operating cash flow is negative at -1839226910.0 KRW, and its free cash flow is also negative at -1193091330.0 KRW, indicating cash flow challenges.
Profitability metrics for HL Science Co Ltd are negative, with a return on equity of -0.0162 and a return on assets of -0.0157. These figures suggest the company is not generating returns for its shareholders or effectively utilizing its assets. The company's operating income is negative at -2228320630.0 KRW, and its net income is also negative at -1637350640.0 KRW, indicating a significant loss.
The company's revenue concentration and geographic exposure are not disclosed in the available data. However, the absence of detailed segment or geographic breakdowns suggests a lack of transparency in its revenue sources.
HL Science Co Ltd's growth trajectory is not clearly defined in the available data. The company's recent financial performance shows a decline in profitability, with a negative operating income and net income. The absence of specific growth metrics or outlooks makes it difficult to assess the company's future performance.
The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights potential liquidity constraints. The company's dilution potential is low, with no significant dilution sources identified in the available data.
Recent events and filings for HL Science Co Ltd are not detailed in the available data. The company's financial performance and risk factors are primarily derived from its latest financial snapshot, with no additional context provided from recent transcripts or filings.
- HL Science Co Ltd has a strong equity position with a negligible debt-to-equity ratio.
- The company is experiencing significant financial losses, with negative operating and net income.
- Liquidity is assessed as medium, with a high current ratio but negative operating and free cash flows.
- The company's profitability metrics are negative, indicating poor returns for shareholders.
- There is a lack of detailed information on revenue concentration and geographic exposure.
- The company's dilution risk is low, but it faces potential liquidity constraints due to negative net cash.
Bull / Bear case
Generated · model-assistedThe company maintains a zero debt-to-equity ratio, ranking in the top quartile of the Food Processing cohort.
Cash conversion metrics exceed the cohort median, indicating relatively efficient working capital management compared to peers.
Capital expenditure relative to revenue is above the cohort median, suggesting lower reinvestment intensity than competitors.
The company faces high credit risk and medium liquidity risk, highlighting significant financial stability concerns.
In focus — financials by report
Revenue KRW 104.38B; Operating income KRW 14.77B.
- ▍Revenue KRW 104.38B
- ▍Operating income KRW 14.77B
- ▍Net margin 13.0%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- HL Science Co Ltd Market data — financials · 2026-05-26